• Prevtec microbia

  Participated · Equity · Mar 2017

  Prevtec Microbia is a Canadian biotechnology company developing biological products for the prevention of diseases in food animals. Its core products include swine E. coli vaccines Coliprotec F4 and the bivalent Coliprotec F4/F18, the latter receiving EU-wide marketing authorization in January 2017. Coliprotec F4 has been sold across Canada since 2007 and received EU marketing authorization in March 2015. The company reports a portfolio of technologies including three commercialized vaccines and aims to become a benchmark for biological products that can replace antibiotics in animals. Prevtec received a CAD $2.5 million investment from shareholders to support the launch of its second vaccine in the EU and to expand its European team to manage demand. Its partner and distributor Elanco plans to launch Coliprotec F4/F18 in May 2017, and Prevtec targets a European swine market of about 250 million heads annually. Prevtec Microbia is a Canadian biotechnology company developing biological products to prevent diseases in food animals, headquartered in Montreal, Quebec. Its first commercial product, Coliprotec-F4, a live oral swine E. coli vaccine, has been sold across Canada since 2008 and received a positive opinion from the European Committee for Medicinal Products for Veterinary Use in March 2015. The company is working to commercialize Coliprotec-F4 in Europe and to secure approval for another vaccine in Europe. Prevtec projects a target market of roughly 250 million animals per year and, under its five-year plan, aims to position itself in 12 countries on four continents with three products commercialized. Financially, the company secured a $7.2 million financing round that includes a $2.5 million equity investment from Investissement Québec to accelerate commercialization and strategic development. Prevtec Microbia develops technologies to improve animal health and is led by Michel Fortin, President and CEO. Its core commercial product is Coliprotec®F4, an E.coli vaccine for swine, which the company has sold in Canada since 2008 and which is also registered in Brazil and other countries. In January 2015 the European Committee for Medicinal Products for Veterinary Use issued a positive opinion recommending EU market authorization for Coliprotec®F4. Prevtec has secured a distribution agreement with Elanco for commercialization of Coliprotec®F4 in the European Union. The company completed a $4.7M financing and intends to use the proceeds to increase its commercial development efforts. Up to 36% of the financing was provided by current shareholders and the remaining 64% ($3.0M) was provided by a venture fund focused on animal health.

• Interset

  Participated · Equity · Mar 2015

  Interset develops a user behavior analytics (UBA) platform that uses machine learning and patented predictive analytics-based risk scoring to assign risk to accounts, machines, files, and digital assets. The platform automates sifting through billions of log files and terabytes of events to surface anomalous behaviors and convey them with actionable, contextual information. Interset emphasizes reducing noise and false positives and presenting analysts with inherently actionable notifications via an intuitive user interface that visually depicts threat stages. The solution uses agentless data collectors, lightweight endpoint sensors, and a scalable, extensible architecture. Interset reports deployments across manufacturing, life sciences, high-tech, finance, government, aerospace and defense, and securities brokerage industries. A strategic investment and technology development agreement with In-Q-Tel is intended to advance further development of the UBA platform. Interset's platform connects siloed data sources — application and OS logs, identity repositories, security tools and endpoints — to correlate millions of events and surface prioritized, actionable threats. Its patent-pending behavioral analytics engine applies multiple mathematical frameworks to identify threats from single or corroborating datasets, and the solution uses agentless collectors, lightweight endpoint sensors and an intuitive UI. Customers span manufacturing, defense, technology, energy, pharmaceuticals, life sciences, finance, government and securities brokerage; Surescripts is named as a customer using Interset to monitor data exits and reduce noise. The company emphasizes rapid detection of targeted insider and outsider attacks and is building new threat visualizations, including a multidimensional kill-chain view. Interset plans to expand platform capabilities, accelerate customer adoption and develop OEM partnerships, such as the recently announced source-code threat protection solution with Perforce Software. Leadership includes president and CEO Dale Quayle, previously CEO of Integrien (sold to VMware in 2010).

• FileTrek

  Led · Series B · Feb 2012

  FileTrek is a newly launched cloud storage and file-sharing platform designed for enterprises. The application enables secure file sharing, project collaboration, and manager visibility across thousands of desktops and mobile devices. Users can share files from their desktop and access data anywhere, online or offline, while all document versions automatically back up and sync in real time. FileTrek reports file location, who has worked on files, changes made, and relationships between files. It offers audit-trail reporting to help large businesses meet compliance needs by providing IT and management visibility into sharing, syncing, and versioning activities. For larger enterprises, FileTrek also provides an internal storage option that lets companies host data on their own servers rather than using the public cloud. The company has raised $10 million in a Series B as it launches.

• Woozworld

  Led · Equity · Aug 2011

  Woozworld operates a user-generated social game and virtual world aimed at tweens (ages 9–14), enabling users to build entire worlds, virtual businesses, restaurants, hotels and games. The company intends to expand its services to mobile platforms and boost marketing to grow reach. Woozworld raised $6 million in new funding from Telesystem, iNovia Capital, and unnamed angel investors. It has registered more than 7 million avatars and more than 14 million virtual spaces created in 18 months. The user base has more than tripled over the last six months; Woozworld reports over 15 million monthly unique visitors from more than 180 countries and more than 76 million monthly page views. Bernard Gershon, former senior vice president and general manager at The Walt Disney Company and current president of GershonMedia, has joined the company’s board of advisors. Woozworld is a Web 2.0 virtual world for tweens that lets users build a shared world, design virtual spaces, set up activities and run virtual businesses. The service claims over 350,000 members and one million user-generated virtual spaces (up from about 50 at the end of last year). Launched in December 2009 and incubated by Tribal Nova, Woozworld will spin off from Tribal Nova following the new funding. The company raised $3 million in Series A financing led by iNovia Capital and ID Capital (a division of Telesystem Group). Proceeds are intended to continue development and promotion of the platform for tween users. Chris Arsenault of iNovia Capital and Daniel Cyr of ID Capital will join the spin-off’s board of directors.

No current team members are available.